van Merode Godefridus G, Groothuis Siebren, Schoenmakers Milou, Boersma Hendrikus H
Department of Health Organization, Policy and Economics, Maastricht University, The Netherlands. F.vanMerode@ beoz.unimaas.nl
Health Care Manag Sci. 2002 Apr;5(2):97-102. doi: 10.1023/a:1014420730473.
Chemotherapy patients are treated with cytostatic drugs. Cytostatic drugs can be produced if ordered or they can be produced to keep in stock. The time that cytostatic drugs can be kept in stock before being spoiled is limited. It is always possible that the patient cannot receive chemotherapy because he/she is not in the right condition. A simulation model is presented which allows to calculate for each combination of patient type and cytostatic drug type the effects on waiting times and costs. In practice actors will behave not as recommended by the simulation model. The cause of the latter is analyzed and solutions are proposed.
化疗患者使用细胞毒性药物进行治疗。细胞毒性药物可以根据订单生产，也可以生产后储存备用。细胞毒性药物在变质前的储存时间是有限的。患者因身体状况不佳而无法接受化疗的情况总是有可能发生的。本文提出了一个模拟模型，该模型可以针对每种患者类型和细胞毒性药物类型的组合，计算对等待时间和成本的影响。在实际中，参与者的行为可能并不如模拟模型所建议的那样。分析了后者产生的原因并提出了解决方案。
